Anionic pulmonary surfactant lipid regulation of innate immunity

References

• Wright JR. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5(1), 58–68 (2005).
   PubMed Web of Science ®Google Scholar
• Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147(1), 218–233 (1993).
   PubMed Web of Science ®Google Scholar
• Nieman GF, Bredenberg CE, Clark WR, West NR. Alveolar function following surfactant deactivation. J. Appl. Physiol. 51(4), 895–904 (1981).
   PubMed Web of Science ®Google Scholar
• Enhorning G, Holm BA. Disruption of pulmonary surfactant’s ability to maintain openness of a narrow tube. J. Appl. Physiol. 74(6), 2922–2927 (1993).
   PubMed Web of Science ®Google Scholar
• Schmidt R, Meier U, Markart P et al. Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease. Am. J. Physiol. Lung Cell Mol. Physiol. 283(5), L1079–L1085 (2002).
   PubMedGoogle Scholar
• Wright SM, Hockey PM, Enhorning G et al. Altered airway surfactant phospholipid composition and reduced lung function in asthma. J. Appl. Physiol. 89(4), 1283–1292 (2000).
   PubMed Web of Science ®Google Scholar
• Zuo YY, Veldhuizen RA, Neumann AW, Petersen NO, Possmayer F. Current perspectives in pulmonary surfactant – inhibition, enhancement and evaluation. Biochim. Biophys. Acta 1778(10), 1947–1977 (2008).
   PubMed Web of Science ®Google Scholar
• Numata M, Voelker DR. Sutherland ER Asthma and infections. In: Lung Biology in Health and Disease. Martin RJ, (Eds). Informa Healthcare, NY, USA, 45–165 (2010).
   Google Scholar
• Kuronuma K, Mitsuzawa H, Takeda K et al. Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J. Biol. Chem. 284(38), 25488–25500 (2009).
   PubMed Web of Science ®Google Scholar
• Kandasamy P, Zarini S, Chan ED, Leslie CC, Murphy RC, Voelker DR. Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages. J. Biol. Chem. 286(10), 7841–7853 (2011).
   PubMed Web of Science ®Google Scholar
• Mueller M, Brandenburg K, Dedrick R, Schromm AB, Seydel U. Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J. Immunol. 174(2), 1091–1096 (2005).
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Asai Y, Ogawa T. Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J. Biol. Chem. 278(45), 44205–44213 (2003).
   PubMedGoogle Scholar
• Numata M, Chu HW, Dakhama A, Voelker DR. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc. Natl Acad. Sci. USA 107(1), 320–325 (2010).
   PubMed Web of Science ®Google Scholar
• Numata M, Kandasamy P, Nagashima Y et al. Phosphatidylglycerol suppresses influenza A virus infection. Am. J. Respir. Cell Mol. Biol. 46, 479–487 (2012).
   Google Scholar
• Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care 7(1), 1–7 (2001).
   PubMedGoogle Scholar
• Ware LB, Matthay MA. The acute respiratory distress syndrome. N. Engl. J. Med. 342(18), 1334–1349 (2000).
   PubMed Web of Science ®Google Scholar
• Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169(1), 333–338 (1989).
   PubMed Web of Science ®Google Scholar
• Kline JN, Cowden JD, Hunninghake GW et al. Variable airway responsiveness to inhaled lipopolysaccharide. Am. J. Respir. Crit. Care Med. 160(1), 297–303 (1999).
   PubMed Web of Science ®Google Scholar
• Nagai Y, Akashi S, Nagafuku M et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3(7), 667–672 (2002).
   PubMed Web of Science ®Google Scholar
• Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282(5396), 2085–2088 (1998).
   PubMed Web of Science ®Google Scholar
• Savov JD, Gavett SH, Brass DM, Costa DL, Schwartz DA. Neutrophils play a critical role in development of LPS-induced airway disease. Am. J. Physiol. Lung Cell Mol. Physiol. 283(5), L952–L962 (2002).
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4(7), 499–511 (2004).
   PubMed Web of Science ®Google Scholar
• Shimizu T, Kida Y, Kuwano K. A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappa B through TLR1, TLR2, and TLR6. J. Immunol. 175(7), 4641–4646 (2005).
   PubMed Web of Science ®Google Scholar
• Seya T, Matsumoto M. A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2. Int. J. Biochem. Cell Biol. 34(8), 901–906 (2002).
   PubMed Web of Science ®Google Scholar
• Aliprantis AO, Yang RB, Mark MR et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285(5428), 736–739 (1999).
   PubMed Web of Science ®Google Scholar
• Ozinsky A, Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl Acad. Sci. USA 97(25), 13766–13771 (2000).
   PubMed Web of Science ®Google Scholar
• Kurt-Jones EA, Popova L, Kwinn L et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1(5), 398–401 (2000).
   PubMed Web of Science ®Google Scholar
• Hall CB. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344(25), 1917–1928 (2001).
   PubMed Web of Science ®Google Scholar
• MacDowell AL, Bacharier LB. Infectious triggers of asthma. Immunol. Allergy Clin. North Am. 25(1), 45–66 (2005).
   PubMedGoogle Scholar
• Wedzicka JA. Exacerbations: etiology and pathophysiologic mechanisms. Chest 121(5), S136–S141 (2002).
   Google Scholar
• Glezen WP. Clinical practice. Prevention and treatment of seasonal influenza. N. Engl. J. Med. 359(24), 2579–2585 (2008).
   PubMed Web of Science ®Google Scholar